Clinical trial

Single-Centre Study of VR040(Inhaled Apomorphine) in Idiopathic Parkinson's Disease

NCT01683292

Study summary

ClinicalTrials.gov

Single-Centre Study of VR040(Inhaled Apomorphine) in Idiopathic Parkinson's Disease

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention Inhaled VR040 Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo for VR040 Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2006-01-01

PhasePHASE2

Conditions

Parkinson's Diseaseverified · MONDO: Parkinson disease

Interventions

Inhaled VR040DRUG

Placebo for VR040DRUG

Sponsors & collaborators

South Glasgow University Hospitals NHS Trustlead sponsor

Vectura Limitedcollaborator

Mapped research locations

GlasgowUnited Kingdom1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01683292 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.